🫁 How can we better support #lungcancer survivors? Join the #ESMODeepDive webinar on #survivorship: PROs, screening, prevention & more.

🔗 Register now with your ESMO membership: https://ow.ly/L1x450XezYO

🌐 #ESMODeepDive webinar: #MIBC - from evidence to practice with ctDNA, perioperative optimisation & bladder‑sparing.

Live Q&A 💬 ESMO member: register to secure your seat: 🔗 https://ow.ly/zXQK50Y5hbt

#ESMOWebinar #ESMOOnAir #BladderCancer #Oncology #PrecisionMedicine

Lars Dyrskjøt Nick James

👉 In this #ESMODeepDive, we turn the complexity of high‑risk localised #ProstateCancer into practical decisions—risk stratification, multimodal strategies, and biochemical recurrence—plus live Q&A

🔗 https://ow.ly/b6aH50YUUwA

Deborah Mukherji Stephen J. Freedland, MD
#ESMOWebinar #ESMOOnAir

🌐Join this #ESMODeepDive to refine treatment sequencing, manage variant histologies, and apply biomarker‑driven care.
Live Q&A 💬 ESMO member: register to secure your seat:
🔗 https://ow.ly/E5qk50YoqoX

Live viewers earn 2 ESMO‑MORA Category 1 points
#ESMOWebinar #ESMOOnAir

👉 In this #ESMODeepDive, we address the challenge of first-line therapy for HRD-negative advanced #OvarianCancer, from HRD testing limitations to PARP inhibitor maintenance and emerging antibody-drug conjugates.

ESMO members: https://ow.ly/3HNN50ZF3Gm

#ESMOOnAir

👉 In this #ESMODeepDive, we turn the complexity of metastatic castration-resistant #ProstateCancer into practical decisions—optimising treatment across the disease course & refining patient selection for emerging approaches

🔗 ESMO members: https://ow.ly/MGy750ZgKCn

#ESMOOnAir

👉 In this #ESMODeepDive, we turn mHSPC complexity into practical decisions—treatment optimisation, sequencing & emerging data. Plus live Q&A 💬

🔗 ESMO member: secure your seat: https://ow.ly/2JRm50ZbJ5R

#ESMOWebinar #ESMOOnAir

🌐 Join this #ESMODeepDive to navigate RCC heterogeneity, tailor first‑ & second‑line strategies & align diagnostics with clinical benefit

Live Q&A 💬 ESMO member, register now:
🔗 https://ow.ly/ECke50YAIOR

Live viewers earn 2 ESMO‑MORA Category 1 points

#ESMOWebinar #ESMOOnAir